Clinical Trial Update: Clinical Importance of Carrier Status of Recessive Gene Mutations in Myopathy (CICS)

View source ↗

Summary

This clinical trial update discusses the clinical importance of carrier status for recessive gene mutations in myopathy (CICS). It lists sponsor Rigshospitalet,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopathy

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Recessive Gene Myopathies | Status: UNKNOWN